Technology | August 06, 2013

CIRS announces Stereotactic End-to-End Verification Phantom at AAPM Annual Meeting

Cirus Inc. STEEV QA System Radiosurgery Radiation Therapy Phantom

August 6, 2013 — CIRS will introduce the Stereotactic End-to-End Verification Phantom (STEEV) at the 55th Annual AAPM Meeting and Exhibition on August 4 to 8 in Indianapolis.

CIRS Stereotactic End-to-End Verification Phantom (STEEV™) shown with 12 optional inserts.

STEEV is a QA tool for evaluating stereotactic radiosurgery (SRS) system performance during commissioning and daily systems checks. To facilitate patient QA, STEEV serves as a surrogate patient to assess every step of the treatment process- from immobilization and multi-modality imaging (computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)) to thorough treatment plan verification. STEEV's anthropomorphic, tissue-equivalent design makes it the only phantom to account for the challenging effects of tissue heterogeneity.

SRS is a non-invasive procedure that focuses high doses of radiation to destroy tumor volumes in small areas of the body. The procedure necessitates a high degree of accuracy in target localization and dose delivery, because small errors can result in significant under treatment of portions of the tumor volume or overdose of nearby healthy tissues. By providing challenging system checks, STEEV helps to identify system errors and ultimately leads to better patient outcomes- a key component to CIRS' company values.

The introduction of STEEV compliments CIRS' existing suite of site-specific end-to-end QA phantoms, including the Dynamic Thorax Phantom, Dynamic Pelvis Phantom and SBRT Thorax Phantom.

For more information: www.cirsinc.com 

Related Content

News | Radiation Therapy

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
Subscribe Now